1. Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum. Issue 10321 (15th January 2022) Authors: Dejnirattisai, Wanwisa; Shaw, Robert H; Supasa, Piyada; Liu, Chang; Stuart, Arabella SV; Pollard, Andrew J; Liu, Xinxue; Lambe, Teresa; Crook, Derrick; Stuart, Dave I; Mongkolsapaya, Juthathip; Nguyen-Van-Tam, Jonathan S; Snape, Matthew D; Screaton, Gavin R Journal: Lancet Issue: Volume 399:Issue 10321(2022) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. Issue 10318 (18th December 2021) Authors: Munro, Alasdair P S; Janani, Leila; Cornelius, Victoria; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Gokani, Karishma; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; va... Journal: Lancet Issue: Volume 398:Issue 10318(2021) Page Start: 2258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗